Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

SQZ Biotechnologies to Present at Upcoming Investor Conferences


SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that Armon Sharei, Ph.D., Chief Executive Officer and Founder of SQZ Biotechnologies, will present at the Bank of America Securities 2022 Healthcare Conference on May 10, in Las Vegas, Nevada and at the H.C. Wainwright Global Investment Conference on May 25, in Miami, Florida. Presentation times and webcast information are available below.

PRESENTATION DETAILS

Tuesday, May 10
Bank of America Securities 2022 Healthcare Conference
5:00-5:30 p.m. ET / 2:00-2:30 p.m. PT
Webcast

Wednesday, May 25
H.C. Wainwright Global Investment Conference
9:30-10:00 a.m. ET
Webcast

Conference webcast details and the company's most recent corporate overview presentation will be available on the Investors section of the SQZ website. Replays will be available for 90 days.

About SQZ Biotechnologies

SQZ Biotechnologies Company is a clinical-stage biotechnology company focused on unlocking the full potential of cell therapies for patients around the world and has active programs in oncology, autoimmune and infectious diseases, as well as additional exploratory initiatives to support future pipeline growth. The company's proprietary Cell Squeeze® technology offers the unique ability to deliver multiple biological materials into many cell types to engineer what we believe can be a broad range of potential therapeutics. With demonstrated production timelines under 24 hours and the opportunity to eliminate preconditioning and lengthy hospital stays, our approach could significantly broaden the therapeutic range and accessibility of cell therapies. The company's first therapeutic applications seek to generate target-specific immune responses, both in activation for the treatment of solid tumors and infectious diseases, and in immune tolerance for the treatment of autoimmune diseases. For more information, please visit www.sqzbiotech.com.


These press releases may also interest you

at 23:00
Today, TELUS Health released its TELUS Mental Health Index ("the Index") with reports that examine the mental health of employed people in the United Kingdom, the United States, Canada, Europe, Singapore, New Zealand and Australia. The UK Index...

at 22:52
Asep Medical Holdings Inc. ("Asep Inc." or the "Company")  is pleased to announce that it is holding an online webinar on March 22, 2024, at 4:00 pm EST to provide significant updates on the company's latest milestones....

at 22:24
Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical leader in the...

at 22:07
Waterdrop, an industry leader in water filtration, is thrilled to announce the launch of its most advanced water filtration system - the Waterdrop X Series Reverse Osmosis System. This state-of-the-art product revolutionizes water purification with...

at 20:56
ICP DAS-BMP dazzled at the prestigious MD&M West Show, where its high-quality medical-grade thermoplastic polyurethane (TPU) garnered orders from top manufacturers in U.S. and Japan. Concurrently, part of the company's TPU products passed the...

at 20:35
Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, solidifies its stature as a frontrunner in the global healthcare sector by securing the T+ Employer® certification for healthcare excellence every year...



News published on and distributed by: